---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-007423"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T06:58:00.854250+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Annovis Bio holds webinar Jan 28, 2026; no clinical or financial data furnished

## Summary
- Company conducted a webinar with CEO Maria Maccecchini; no new results or data disclosed in filing.
- Exhibit 99 contains only a title slide and standard forward-looking statement, no financial or clinical details.
- No guidance, trial updates, or material business developments were provided in the 8-K exhibit.
- Filing is procedural Regulation FD disclosure for the webinar event itself, not a substantive update.

## SEC filing metadata
- accession: 0001104659-26-007423
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465926007423/0001104659-26-007423-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465926007423/tm264292d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-007423
- JSON: https://secwatch.observer/filing/0001104659-26-007423.json
- Plain text: https://secwatch.observer/filing/0001104659-26-007423.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.